We are pleased to report to our clients and others that the Takeda defendants in the Actos litigation have recently proposed a global settlement of up to $2.4 Billion that may resolve close to 9,200 pending bladder cancer cases. Given our work on these claims over the last few of years, we believe this is a very positive development and further hope it will take care of a lot of very deserving clients and families. We are in the process now of contacting all our existing clients to inform them of the same and provide more detailed information on the Actos settlement proposal.
Some of the basic details can be find in this New York Times article: Takeda Agrees to Pay $2.4 Billion to Settle Suits Over Cancer Risk of Actos
Other Actos News
The diabetes drug Actos (generic: pioglitazone) has been linked to […]
Actos, the popular diabetes drug, also known as pioglitazone, has […]
Two European countries have removed the prescription diabetes drug Actos […]
